Rockwell Medical Inc
NASDAQ:RMTI

  • LAST PRICE
    1.7000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    1.6800/ 1
  • Ask / Lots
    1.8000/ 50
  • Open / Previous Close
    1.8000 / 1.7000
  • Day Range
    1.6900
    1.9300
  • 52 Week Range
    1.1600
    6.2400
  • Volume
    261,868

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Today

      Show headlines and story abstract

    • 11 hours ago by MT Newswires
      Companies Mentioned: RMTI
      06:01 AM EDT, 05/14/2024 (MT Newswires) -- ...

    • 11 hours ago by Business Wire
      Companies Mentioned: RMTI

      Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three months ended March 31, 2024.

    • 11 hours ago by Dow Jones
      Companies Mentioned: RMTI
      ------------ ------------ Net Loss $ (1,731) $ (1,750) ============ ============ Basic and Diluted Net Loss per Share $ (0.06) $ (0.10) ============ ============ Basic and Diluted Weighted Average Shares Outstanding 29,327,204 18,359,940 ============ ============ Reconciliation to GAAP Financial Measures (In Thousands, Except Shares and Per Share Amounts) Three Months Ended March 31 ---------------------------- 2024 2023 ---------- ---------- Net Loss $ (1,731) $ (1,750) Income taxes Interest expense 431 387 Depreciation and amortization 544 159 ---------- ---------- EBITDA (757) (1,205) Severance costs - 29 Stock-based compensation 251 193 Adjusted EBITDA $ (506) $ (982) ========== ========== Adjusted EPS $ (0.02) $ (0.05) ========== ========== Basic and Diluted Weighted Average Shares Outstanding 29,327,204 18,359,940 ========== ========== Reconciliation to GAAP Financial Measures (Dollars in Thousands) Three Months Ended March 31 ------------------------ 2024 2023 ------- ------ Net Sales $ 22,676 $19,668 Deferred Revenue - (1,472) ------- ------ Net Sales excluding Deferred Revenue 22,676 18,197 Gross Profit 3,064 2,599 Deferred Revenue - (1,472) ------- ------ Gross Profit excluding Deferred Revenue $ 3,064 $ 1,128 Net Loss (1,731) (1,750) Deferred Revenue 0 (1,472) ------- ------ Net Loss excluding Deferred Revenue $ (1,731) $(3,222)

    • 11 hours ago by Dow Jones
      Companies Mentioned: RMTI

  • Apr 17, 2024

Peers Headlines